首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1563387

藥物篩檢市場規模、佔有率、成長分析、按產品和服務、按樣本類型、按藥物類型、按最終用戶、按地區 - 行業預測，2024-2031 年

Drug Screening Market Size, Share, Growth Analysis, By Product & Service, By Sample Type, By Drug Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球藥物篩檢市場規模為89億美元，從2023年的103.7億美元成長到2031年的351.8億美元，預計複合年成長率為16.5%。

全球藥物篩檢市場在醫療保健領域迅速擴張，重點是個別藥物及其代謝物的檢測。這個市場在職場、醫院、體育組織和執法部門等各種環境中都至關重要，有助於識別使用非法物質和濫用處方藥的人。有幾個因素推動藥物篩檢市場的成長。一個主要因素是藥物濫用和成癮現像日益普遍，增加了對有效篩檢技術的需求。隨著世界各國政府和組織越來越認知到藥物濫用的社會和經濟影響，強制進行藥物檢測的法規和政策變得越來越嚴格。此外，隨著對職場安全的日益重視，許多公司正在實施無毒品政策，以提高員工生產力、減少工作場所事故並限制法律風險。此外，藥物篩檢技術的進步以及各領域對高可靠檢測方法的需求也支持了市場的擴張。由於這些因素和不斷變化的法規，藥物篩檢的重要性不斷增加，預計未來幾年將進一步成長，持續的技術創新將塑造市場的未來。

市場概況
藥物篩檢服務
- 實驗室測試服務
- 現場測試服務
藥物篩檢產品
- 分析設備
- 按類型
- 酒精檢測儀
- 燃料電池酒精檢測儀
- 半導體酒精檢測儀
- 其他酒精檢測儀
- 免疫檢測分析儀
- 層析法設備
- 按方式
- 手持式藥物篩檢產品
- 桌上型藥物篩檢產品
- 快速檢測裝置
- 尿液檢查裝置
- 藥物測試杯
- 浸卡
- 藥物測試盒
- 口腔液檢測裝置
- 消耗品
- 檢測試劑套件
- 樣本採集裝置
- 校準器和控制裝置
- 其他消耗品

藥物篩檢市場：依樣本類型

市場概況
尿液樣本
呼吸樣本
口腔液樣本
頭髮樣本
其他樣品

藥物篩檢市場：依藥物類型

市場概況
大麻
酒精
古柯鹼
鴉片類藥物
安非他命和甲基安非他命
其他藥品

藥物篩檢市場：依最終用戶分類

市場概況
藥物檢測實驗室
工作場所
刑事司法系統與執法
醫院
戒毒治療中心
個人用戶
疼痛管理中心
學校和大學
其他最終用戶

藥物篩檢市場規模：依地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Quest Diagnostics（US）
Abbott（US）
OraSure Technologies Inc.（US）
Alfa Scientific Designs Inc.（US）
Thermo Fisher Scientific Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Lifeloc Technologies, Inc.（US）
MPD Inc.（US）
Omega Laboratories, Inc.（US）
Premier Biotech, Inc.（US）
Psychemedics Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Shimadzu Corporation（Japan）
Siemens Healthineers AG（Germany）
American Bio Medica Corporation（US）
ACM Global Laboratories（US）
CareHealth America Corp.（US）
Clinical Reference Laboratory, Inc.（US）
Intoximeters（US）
Sciteck, Inc.（US）
AccuSourceHR, Inc.（US）
Cordant Health Solutions（US）
Intoxalock（US）
Millennium Health（US）
AdvaCare Pharma（US）

簡介目錄

Product Code: SQMIG35D2198

Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031).

The global drug screening market is expanding rapidly within the healthcare sector, focusing on detecting drugs or their metabolites in individuals. This market is essential across multiple environments, including workplaces, hospitals, sports organizations, and law enforcement agencies, where it helps identify those using illegal substances or misusing prescription drugs. Several factors are fueling the growth of the drug screening market. A major driver is the increasing prevalence of drug abuse and addiction, which has heightened the demand for effective screening techniques. Governments and organizations worldwide are becoming more aware of the social and economic impacts of drug abuse, leading to stricter regulations and policies that mandate drug testing. Additionally, there is a growing emphasis on workplace safety, with many companies implementing drug-free policies to enhance employee productivity, reduce workplace accidents, and limit legal risks. The market's expansion is also supported by advancements in drug screening technology and the need for reliable testing methods in various sectors. As the importance of drug screening continues to rise, driven by these factors and evolving regulations, the market is expected to grow further in the coming years, with ongoing innovations shaping its future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Screening Market Segmental Analysis

Global Drug Screening Market is segmented by Product & Service, Sample Type, application, end user and region. Based on Product & Service, the market is segmented into Drug Screening Services, and Drug Screening Products. Based on Sample Type, the market is segmented into Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, and Other Samples. Based on Drug Type, the market is segmented into Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, and Other Drugs. Based on end user, the market is segmented into Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Drug Screening Market

The growing use of drug screening products and services on the road is expected to drive the overall expansion of the market, particularly as the prevalence of illicit drug use increases. Additionally, rising drug use among teenagers is likely to further boost market growth. The ease of implementing drug screening and its effectiveness in workplace testing are also contributing factors to this market expansion. However, the increase in government spending to combat drug trafficking may moderate the market's growth. Despite this, the market is anticipated to benefit from the rising incidence of traffic accidents related to drugged driving and prescription medication abuse, which will further accelerate its growth in the future.

Restraints in the Global Drug Screening Market

In certain environments, particularly workplaces, drug testing is perceived as an invasion of employee privacy, which is likely to hinder market growth. These privacy concerns may lead to resistance and slow the expansion of the drug screening market. Additionally, the industry faces potential challenges from regional restrictions on drug use and issues with the accuracy of breathalyzers. These factors could further impact the growth and adoption of drug screening solutions in various settings.

Market Trends of the Global Drug Screening Market

The global drug screening market is evolving with several prominent trends shaping its development. One major trend is the increasing adoption of advanced technologies, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays. These innovations are improving the sensitivity and accuracy of drug testing methods, enhancing the overall effectiveness of screening procedures. Another notable trend is the rising emphasis on oral fluid drug testing. Saliva-based tests offer a non-invasive and convenient alternative to traditional urine and blood tests. Although they have a shorter detection window, oral fluid tests provide real-time detection of drug use, making them particularly useful for post-accident and roadside testing. The market is also seeing growth in rapid on-site testing, expanded drug panels, and the integration of artificial intelligence (AI) and machine learning (ML). These advancements are aimed at increasing the accuracy, convenience, and efficiency of drug screening processes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Drug Screening Market by Product & Service

Market Overview
Drug Screening Services
- Laboratory Testing Services
- On-site Testing Services
Drug Screening Products
- Analytical Instruments
- By Type
- Breathalyzers
- Fuel-cell Breathalyzers
- Semiconductor Breathalyzers
- Other Breathalyzers
- Immunoassay analyzers
- Chromatography instruments
- By Modality
- Hand-held drug screening products
- Benchtop drug screening products
- Rapid Testing Devices
- Urine testing devices
- Drug testing cups
- Dip cards
- Drug testing cassettes
- Oral fluid testing devices
- Consumables
- Assay kits
- Sample collection devices
- Calibrators and controls
- Other consumables

Drug Screening Market by Sample Type

Market Overview
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Other Samples

Drug Screening Market by Drug Type

Market Overview
Cannabis
Alcohol
Cocaine
Opioids
Amphetamine And Methamphetamine
Other Drugs

Drug Screening Market by End User

Market Overview
Drug Testing Laboratories
Workplaces
Criminal Justice Systems and Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
Schools And Colleges
Other End Users

Drug Screening Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifeloc Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPD Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Biotech, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
American Bio Medica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareHealth America Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Reference Laboratory, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intoximeters (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AccuSourceHR, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordant Health Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intoxalock (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Millennium Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AdvaCare Pharma (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments